Seres Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
13.43
|
|
Average Rating
|
4.38
|
|
# Strong Buys
|
5
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
1
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.47
|
-0.49
|
-0.02
|
-4.26%
|
|
2022-06-30
|
-0.60
|
-0.70
|
-0.10
|
-16.67%
|
|
2022-03-31
|
-0.52
|
-0.61
|
-0.09
|
-17.31%
|
|
2021-12-31
|
-0.44
|
-0.52
|
-0.08
|
-18.18%
|
|
2021-09-30
|
-0.46
|
0.72
|
1.18
|
256.52%
|
|
2021-06-30
|
-0.37
|
-0.53
|
-0.16
|
-43.24%
|
|
2021-03-31
|
-0.31
|
-0.39
|
-0.08
|
-25.81%
|
|
2020-12-31
|
-0.28
|
-0.23
|
0.05
|
17.86%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.80
|
|
2021-12-31
|
-0.72
|
|
2020-12-31
|
-1.15
|
|
2019-12-31
|
-1.31
|
|
2018-12-31
|
-2.43
|
|
2017-12-31
|
-2.21
|
|
2016-12-31
|
-2.29
|
|
2015-12-31
|
-2.24
|